Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma
Nanoscale · 2024
DOI: 10.1039/d4nr01587h ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Qing Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery I, General Surgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. fangchihua@sm…. Hauptthemen laut MEDLINE: Plectin, Carcinoma, Pancreatic Ductal, Deoxycytidine, Gemcitabine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Schematic diagram depicting the procedures involved in developing the PTP-Lipo-Gem-ICG NPs, as a multipurpose drug delivery platform for chemotherapy-targeted synergistic tumor treatment (By Figdraw).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery I, General Surgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. fangchihua@smu.edu.cn.
- Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou, 510280, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhu, Q., Zeng, S., Yang, J., Zhuo, J., Wang, P., Wen, S., & Fang, C. (2024). Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma. Nanoscale. https://doi.org/10.1039/d4nr01587h
Vancouver
Zhu Q, Zeng S, Yang J, Zhuo J, Wang P, Wen S, et al. Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma. Nanoscale. 2024. doi:10.1039/d4nr01587h
BibTeX
@article{Zhu2024,
author = {Zhu, Qing and Zeng, Silue and Yang, Junying and Zhuo, Jiaming and Wang, Peifeng and Wen, Sai and Fang, Chihua},
title = {Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma},
journal = {Nanoscale},
year = {2024},
doi = {10.1039/d4nr01587h}
}
EUVIMED